Chemical Compound Review:
Lanoxin 4-[3-[5-[5-(4,5-dihydroxy-6- methyl-oxan-2...
Synonyms:
Cogoxin, Digocin, Digoxin 96%, AGN-PC-00YHTD, SureCN126382, ...
- Asymptomatic digoxin toxicity. Harris, M.M., Hariprasad, M.K., Khalid, S. N. Engl. J. Med. (1981)
- Treatment of life-threatening digitalis intoxication with digoxin-specific Fab antibody fragments: experience in 26 cases. Smith, T.W., Butler, V.P., Haber, E., Fozzard, H., Marcus, F.I., Bremner, W.F., Schulman, I.C., Phillips, A. N. Engl. J. Med. (1982)
- Heart failure in outpatients: a randomized trial of digoxin versus placebo. Lee, D.C., Johnson, R.A., Bingham, J.B., Leahy, M., Dinsmore, R.E., Goroll, A.H., Newell, J.B., Strauss, H.W., Haber, E. N. Engl. J. Med. (1982)
- Long-term digitalis therapy improves left ventricular function in heart failure. Arnold, S.B., Byrd, R.C., Meister, W., Melmon, K., Cheitlin, M.D., Bristow, J.D., Parmley, W.W., Chatterjee, K. N. Engl. J. Med. (1980)
- Digoxin therapy and mortality after myocardial infarction. Experience in the MILIS Study. Muller, J.E., Turi, Z.G., Stone, P.H., Rude, R.E., Raabe, D.S., Jaffe, A.S., Gold, H.K., Gustafson, N., Poole, W.K., Passamani, E. N. Engl. J. Med. (1986)
- Molecular pathways: digoxin use and estrogen-sensitive cancers--risks and possible therapeutic implications. Biggar, R.J. Clin. Cancer Res. (2012)
- The serum digoxin test and digoxin toxicity: a Bayesian approach to decision making. Eraker, S.A., Sasse, L. Circulation (1981)
- A V kappa-J kappa junctional change in an antidigoxin recombinant antibody destroys digoxin-binding activity. Hudson, N.W., Bruccoleri, R.E., Steinrauf, L.K., Hamilton, J.A., Mudgett-Hunter, M., Margolies, M.N. J. Immunol. (1990)
- Effects of physical activity and immobilization on plasma digoxin concentration and renal digoxin clearance. Pedersen, K.E., Madsen, J., Kjaer, K., Klitgaard, N.A., Hvidt, S. Clin. Pharmacol. Ther. (1983)
- Visual hallucinations as the earliest symptom of digoxin intoxication. Closson, R.G. Arch. Neurol. (1983)
- Computer assisted prescribing of drugs. Mawer, G.E. Clinical pharmacokinetics. (1976)
- The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. Pitt, B., Zannad, F., Remme, W.J., Cody, R., Castaigne, A., Perez, A., Palensky, J., Wittes, J. N. Engl. J. Med. (1999)
- Images in clinical medicine. Digoxin-induced bidirectional ventricular tachycardia. Valent, S., Kelly, P. N. Engl. J. Med. (1997)
- The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group. Packer, M., Bristow, M.R., Cohn, J.N., Colucci, W.S., Fowler, M.B., Gilbert, E.M., Shusterman, N.H. N. Engl. J. Med. (1996)
- Nifedipine in asymptomatic patients with severe aortic regurgitation and normal left ventricular function. Scognamiglio, R., Rahimtoola, S.H., Fasoli, G., Nistri, S., Dalla Volta, S. N. Engl. J. Med. (1994)
- Effect of quinidine on digoxin concentration in skeletal muscle and serum in patients with atrial fibrillation. Evidence for reduced binding of digoxin in muscle. Schenck-Gustafsson, K., Jogestrand, T., Nordlander, R., Dahlqvist, R. N. Engl. J. Med. (1981)
- A comparison of digoxin and dobutamine in patients with acute infarction and cardiac failure. Goldstein, R.A., Passamani, E.R., Roberts, R. N. Engl. J. Med. (1980)
- Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study. Cohn, J.N., Archibald, D.G., Ziesche, S., Franciosa, J.A., Harston, W.E., Tristani, F.E., Dunkman, W.B., Jacobs, W., Francis, G.S., Flohr, K.H. N. Engl. J. Med. (1986)
- Sinus node dysfunction caused by methyldopa and digoxin. Davis, J.C., Reiffel, J.A., Bigger, J.T. JAMA (1981)
- Effects of digoxin in infants with congested circulatory state due to a ventricular septal defect. Berman, W., Yabek, S.M., Dillon, T., Niland, C., Corlew, S., Christensen, D. N. Engl. J. Med. (1983)
- Decreased bioavailability of digoxin due to antacids and kaolin-pectin. Brown, D.D., Juhl, R.P. N. Engl. J. Med. (1976)
- Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors. RADIANCE Study. Packer, M., Gheorghiade, M., Young, J.B., Costantini, P.J., Adams, K.F., Cody, R.J., Smith, L.K., Van Voorhees, L., Gourley, L.A., Jolly, M.K. N. Engl. J. Med. (1993)
- A digoxin-antibiotic drug interaction. Doherty, J.E. N. Engl. J. Med. (1981)
- Quinidine-digoxin interaction: Pharmacokinetics, underlying mechanism and clinical implications. Doering, W. N. Engl. J. Med. (1979)
- Fetal echocardiography for evaluation of in utero congestive heart failure. Kleinman, C.S., Donnerstein, R.L., DeVore, G.R., Jaffe, C.C., Lynch, D.C., Berkowitz, R.L., Talner, N.S., Hobbins, J.C. N. Engl. J. Med. (1982)
- Expression of a hybrid immunoglobulin-T cell receptor protein in transgenic mice. Becker, M.L., Near, R., Mudgett-Hunter, M., Margolies, M.N., Kubo, R.T., Kaye, J., Hedrick, S.M. Cell (1989)
- Predictors of postoperative myocardial ischemia in patients undergoing noncardiac surgery.The Study of Perioperative Ischemia Research Group. Hollenberg, M., Mangano, D.T., Browner, W.S., London, M.J., Tubau, J.F., Tateo, I.M. JAMA (1992)
- Absence of the mdr1a P-Glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A. Schinkel, A.H., Wagenaar, E., van Deemter, L., Mol, C.A., Borst, P. J. Clin. Invest. (1995)
- A comparison of oral milrinone, digoxin, and their combination in the treatment of patients with chronic heart failure. DiBianco, R., Shabetai, R., Kostuk, W., Moran, J., Schlant, R.C., Wright, R. N. Engl. J. Med. (1989)
- Alteration of digoxin pharmacokinetics by a single dose of quinidine. Chen, T.S., Friedman, H.S. JAMA (1980)
- Inhibition of digoxin absorption by neomycin. Lindenbaum, J., Maulitz, R.M., Butler, V.P. Gastroenterology (1976)
- A novel human hepatic organic anion transporting polypeptide (OATP2). Identification of a liver-specific human organic anion transporting polypeptide and identification of rat and human hydroxymethylglutaryl-CoA reductase inhibitor transporters. Hsiang, B., Zhu, Y., Wang, Z., Wu, Y., Sasseville, V., Yang, W.P., Kirchgessner, T.G. J. Biol. Chem. (1999)
- Involvement of Cdk5/p25 in digoxin-triggered prostate cancer cell apoptosis. Lin, H., Juang, J.L., Wang, P.S. J. Biol. Chem. (2004)
- Human breast cancer resistance protein: interactions with steroid drugs, hormones, the dietary carcinogen 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine, and transport of cimetidine. Pavek, P., Merino, G., Wagenaar, E., Bolscher, E., Novotna, M., Jonker, J.W., Schinkel, A.H. J. Pharmacol. Exp. Ther. (2005)
- P-glycoprotein potentiates CYP3A4-mediated drug disappearance during Caco-2 intestinal secretory detoxification. Chan, L.M., Cooper, A.E., Dudley, A.L., Ford, D., Hirst, B.H. Journal of drug targeting. (2004)
- Interrelationship between substrates and inhibitors of human CYP3A and P-glycoprotein. Kim, R.B., Wandel, C., Leake, B., Cvetkovic, M., Fromm, M.F., Dempsey, P.J., Roden, M.M., Belas, F., Chaudhary, A.K., Roden, D.M., Wood, A.J., Wilkinson, G.R. Pharm. Res. (1999)
- Spurious results of digoxin radioimmunoassay. Vinge, E., Nilsson, L.G., Molin, L., Ekman, R. N. Engl. J. Med. (1984)
- Interaction between quinidine and digoxin. Leahey, E.B., Reiffel, J.A., Drusin, R.E., Heissenbuttel, R.H., Lovejoy, W.P., Bigger, J.T. JAMA (1978)